13F HOLDINGS REPORT
Aquilo Capital Management, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001591986-24-000005
Total Value
$133.4M
Positions
10
Other Managers
0
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 908,474 | $26.0M | 19.47% |
| 2 | REGENXBIO INC | RGNX | 906,248 | $19.1M | 14.31% |
| 3 | BLUEPRINT MEDICINES CORP | 09627Y109 | 182,151 | $17.3M | 12.95% |
| 4 | ARVINAS INC | ARVN | 405,766 | $16.8M | 12.55% |
| 5 | KYMERA THERAPEUTICS INC | KYMR | 388,743 | $15.6M | 11.71% |
| 6 | SILENCE THERAPEUTICS PLC | SLNCF | 574,214 | $12.4M | 9.30% |
| 7 | MERUS N V | N5749R100 | 255,109 | $11.5M | 8.61% |
| 8 | SUTRO BIOPHARMA INC | STRO | 1,165,466 | $6.6M | 4.94% |
| 9 | PRECISION BIOSCIENCES INC | DTIL | 385,440 | $5.2M | 3.92% |
| 10 | REPARE THERAPEUTICS INC | 760273102 | 633,271 | $3.0M | 2.24% |